SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-140615
Filing Date
2024-05-16
Accepted
2024-05-16 16:28:13
Documents
21
Period of Report
2024-03-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819924d8k.htm   iXBRL 8-K 28324
2 EX-99.1 d819924dex991.htm EX-99.1 669301
3 EX-99.2 d819924dex992.htm EX-99.2 694610
7 GRAPHIC g819924sp14.jpg GRAPHIC 240952
8 GRAPHIC g819924sp15.jpg GRAPHIC 233860
9 GRAPHIC g819924sp16.jpg GRAPHIC 127072
10 GRAPHIC g819924sp33.jpg GRAPHIC 261467
11 GRAPHIC g819924sp34.jpg GRAPHIC 257916
12 GRAPHIC g819924sp35.jpg GRAPHIC 144508
  Complete submission text file 0001193125-24-140615.txt   3300628

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA phasq-20240322.xsd EX-101.SCH 2514
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE phasq-20240322_lab.xml EX-101.LAB 17946
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phasq-20240322_pre.xml EX-101.PRE 11236
25 EXTRACTED XBRL INSTANCE DOCUMENT d819924d8k_htm.xml XML 3761
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 24956019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)